Category: Cost & Quality

Community Paramedicine: Can It Help Your High-Risk Patients?

By: Rahul Sanghera
Date: February 12, 2019
Category: Cost & Quality
Filed under: American Heart Month, Community Medicine, Heart Disease, Heart Failure, Heart Health, Paramedicine

Though February is traditionally considered the month of sweethearts, it also holds important significance for the healthcare community, as February is American Heart Month! Per the Centers for Disease Control and Prevention, 1 in 3 adults in the United States suffer from high blood cholesterol levels, and the American Heart Association predicts that by 2035, […]

Hello Horizons: A Preview of CQA’s Revamped Yearly Roadmap

By: Bob Modlinski
Date: January 31, 2019
Category: Cost & Quality
Filed under: behavioral health, Change Culture, Consumerism, Environmental Safety, Patient Satisfaction, Physician Engagement, population health

Every January since 2013, HBI’s Cost & Quality Academy has been giving its members a preview of the upcoming year’s prominent trends in the healthcare industry. The annual Thesis report provided prospective topical insight and solutions to common challenges in areas such as patient care experience and delivery, population and disease management, and regulatory changes. […]

How to Avoid Using Restraints on Aggressive Patients

By: Anna Miller
Date: January 15, 2019
Category: Cost & Quality
Filed under: behavioral health, de-escalation, escalating scenarios, patient aggression, restraints

In 2018, HBI’s Cost & Quality Academy received a number of Analyst Advisory requests related to de-escalating patient aggression, indicating a growing industrywide focus on properly managing patients who exhibit aggressive behavior. Because physical and pharmacological restraints should be used as a last resort, below we have shared strategies for preventing and managing escalating scenarios […]

Heart Failure Treatment: 4 Key Takeaways From Our Latest Best Practice Report

By: Kshipra K
Date: December 27, 2018
Category: Cost & Quality
Filed under: best practice report, care transitions, continuum of care, Heart Failure, heart failure treatment, pharmacological treatment

Heart failure is estimated to be the fourth leading cause of cardiovascular death in the United States and can be incredibly costly for hospitals and health systems due to its high readmission rate. As such, we decided to focus our latest best practice report on heart failure, covering four main aspects of care: identification, treatment, […]

4 Key Insights From Our Featured Research on OPPE

By: Vyshnavi Manda
Date: December 20, 2018
Category: Cost & Quality
Filed under: ongoing professional practice evaluation, OPPE, OPPE metrics, peer review, performance evaluation

Ongoing professional practice evaluation (OPPE), a mandated process by The Joint Commission to evaluate and monitor the competency, professional behavior, and performance of practitioners, can often feel a bit overwhelming. To aid you in executing your OPPE process, one of our November featured research pieces answered a number of questions your fellow HBI Cost & […]

A Look Ahead: 3 Healthcare Quality Trends to Know for 2019

By: Sarah Williams
Date: November 20, 2018
Category: Cost & Quality
Filed under: Falls, Healthcare quality, Physician Engagement, Sepsis, Strategic Planning

The fourth quarter poses a challenging balancing act for all organizations: Leaders must simultaneously execute on current priorities while setting strategic focus areas for the year ahead. As 2018 draws to a close, HBI’s Cost & Quality Academy has been polling the membership community in order to identify pressing priorities for the year ahead. After […]

Saturation Genome Editing: Can it Determine Breast Cancer Risk?

By: Bob Modlinski
Date: November 5, 2018
Category: Cost & Quality
Filed under: BRCA 1, breast cancer, cancer risk, genome editing

Just in time for Breast Cancer Awareness Month, a recently published study by cancer researchers at the University of Washington has appeared to do something that no one or organization has done before: Given physicians, patients, and the general public a list of which BRCA1 gene variants are deemed safe and which can potentially cause […]

Severe Maternal Morbidity: Trends and Solutions

By: Vyshnavi Manda
Date: September 27, 2018
Category: Cost & Quality
Filed under: AIM program, disparities, maternal deaths, recommendations, severe maternal morbidity, trends

Women in the United States are becoming injured in childbirth at rising rates that far outpace other developed countries. This occurrence, called severe maternal morbidity, refers to unexpected outcomes of labor and delivery (like hemorrhage) that lead to short- or long-term consequences for women’s health. To address this public health issue, it is important for […]

Learn How to Retain Your Best and Brightest Nurses With This Complimentary Infographic

By: Anna Miller
Date: September 18, 2018
Category: Cost & Quality
Filed under: Nurse retention, nurse turnover, nursing, pipeline development, retention strategies

According to a 2018 report from Nursing Solutions, Inc., the national nursing turnover rate is at 16.8% and rising, and the average cost of each turnover is $49,500—leading many organizations to prioritize nurse retention initiatives. To aid in these efforts, HBI’s Cost & Quality Academy interviewed nurse leaders at Duke University Health System and Mercy […]